The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 6.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 17%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (12 analysts) rates it hold, with a mean price target of $109.
T. Rowe Price
TROW · a US exchange · USD · Market cap $23.0B · 7,507 employees
T.
FAIL · Does not pass the screenAt the last full screen
2026-09-09
Screened 2026-09-09 · the tape above runs as of 15:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markdown label.
T. Rowe Price holds its Markdown at $107.74. The statistical read favours the buyers, held for 33 days.
| Phase | Markdown · caution |
| Quantitative state | The statistical read favours the buyers, held for 33 days |
| Price at the screen | $107.74 |
| Valuation | 10.82 trailing · 10.44 forward price to earnings |
| Values screen | FAIL · score 10.0 |
| Beta | 1.48 |
Five Screens, Shown in Full
Does not pass. Business activity screen
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Business activity: Financials sector | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Our framework reads AVOID: it trades at roughly a 15% discount to our $124.00 fair value, moderate competitive moat, 10.70% revenue growth.
Fair value range in USD, drawn from the 2026-09-09 screen. The gold marker is the market price at the same screen. A 15.1% margin of safety to the base estimate.
Third-party analyst targets: 12 covering, consensus Hold. The average target sits +4% from the screen price.
Reading the gap · Our model sees value the Street hasn't fully caught up to yet.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-09 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsSavings giant trips over its own ethics test
Every monthly contribution into a workplace pension or retail fund travels through an asset manager that still posts a 28 percent profit margin and 19 percent ROE. T. Rowe Price looks steady on paper, yet we pass without hesitation.
The forward multiple of 11.3 times earnings prices in only modest 5 percent revenue growth, and twelve analysts already mark the shares 9 dollars below where they trade today. A moderate moat does little to change the arithmetic when the ethical screen returns a clear fail on business activity grounds.
That single red flag overrides any narrow valuation cushion and keeps the name firmly on the avoid list. Analysis, not advice.
| Forward P/E | 10.4xfairly priced for its growth rate |
| Trailing P/E | 10.8xreasonably valued |
| EPS, trailing | 9.96 |
| EPS, forward | 10.32 |
| Revenue growth | +10.7%steady growth |
| Profit margin | 29.3%healthy profit margins |
| Return on equity | 19.4%a solid return on shareholder capital |
| FCF yield | 8.81% |
| Dividend yield | 494.00% |
| Debt to equity | 3.70heavy leverage: higher risk if revenue softens |
| Current ratio | 4.04comfortably covers its short-term bills |
| Beta | 1.48moves a little more than the market |
| Short interest, float | 0.14% |
| 52-week range | 85.22 - 122.00 |
| Moat | MODERATE |
| Market cap | $23.0B |
| Employees | 7,507 |
The risks · The things to watch: it already moves more than the market on an average day; it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeTROW trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from accumulation to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 8.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 17%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (12 analysts) rates it hold, with a mean price target of $98.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 17%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (12 analysts) rates it hold, with a mean price target of $98.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- T. Rowe Price (TROW) Sees a More Significant Dip Than Broader Market: Some Facts to Know Zacks · 17 Jul 2026
- T. Rowe Price Launches Multi-Crypto ETF Including Bitcoin, Ethereum, and XRP 24/7 Wall St. · 17 Jul 2026
- My $1.6 Million Retirement Account Has an Automatic Annuity Clause if I Die: What Are My Options? 24/7 Wall St. · 17 Jul 2026
- Wall Street Deepens Crypto Push as T. Rowe Price Launches Multi-Token ETF and Citadel Securities Invests $400M in Crypto.com CCN · 17 Jul 2026
- Morgan Stanley’s E*Trade Rolls Out Crypto Trading. Wall Street’s Push Into Digital Assets Continues. Barrons.com · 16 Jul 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-13 | JACKSON STEPHON A. | Officer | 3,000 | $307,680 | |
| 2026-05-13 | JACKSON STEPHON A. | Officer | 175 | $17,198 | |
| 2026-05-08 | WILSON ALAN D | Director | 1,899 | · | |
| 2026-05-08 | STEVENS ROBERT J | Director | 1,899 | · | |
| 2026-05-08 | SMITH CYNTHIA F | Director | 1,899 | · | |
| 2026-05-08 | ROMINGER EILEEN P. | Director | 1,899 | · | |
| 2026-05-08 | VERMA RICHARD R | Director | 1,899 | · | |
| 2026-05-08 | WIJNBERG SANDRA S | Director | 1,899 | · | |
| 2026-05-08 | DUBLON DINA | Director | 1,899 | · | |
| 2026-05-08 | GOLSTON ALLAN C | Director | 1,899 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $104.75 | +1.6% | · | $1,016 | +1.6% |
| 2 months | $91.49 | +16.3% | · | $1,163 | +16.3% |
| 3 months | $86.62 | +22.9% | $1.30 | $1,244 | +24.4% |
| 6 months | $102.17 | +4.2% | $2.57 | $1,067 | +6.7% |
| 1 year | $91.02 | +16.9% | $5.11 | $1,225 | +22.5% |
| 2 years | $104.19 | +2.2% | $10.10 | $1,118 | +11.8% |
| 3 years | $99.11 | +7.4% | $15.00 | $1,225 | +22.5% |
| 5 years | $154.44 | -31.1% | $27.26 | $866 | -13.4% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever TROW does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.